1360 related articles for article (PubMed ID: 16294276)
1. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
Bone; 2003 Dec; 33(6):899-910. PubMed ID: 14678849
[TBL] [Abstract][Full Text] [Related]
3. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
5. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
[TBL] [Abstract][Full Text] [Related]
6. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
7. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
8. Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling.
Ying X; Sun L; Chen X; Xu H; Guo X; Chen H; Hong J; Cheng S; Peng L
Eur J Pharmacol; 2013 Dec; 721(1-3):225-30. PubMed ID: 24076187
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
10. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
11. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3).
Sammons J; Ahmed N; El-Sheemy M; Hassan HT
Stem Cells Dev; 2004 Jun; 13(3):273-80. PubMed ID: 15186723
[TBL] [Abstract][Full Text] [Related]
12. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2.
Jikko A; Harris SE; Chen D; Mendrick DL; Damsky CH
J Bone Miner Res; 1999 Jul; 14(7):1075-83. PubMed ID: 10404007
[TBL] [Abstract][Full Text] [Related]
13. Novel hedgehog agonists promote osteoblast differentiation in mesenchymal stem cells.
Nakamura T; Naruse M; Chiba Y; Komori T; Sasaki K; Iwamoto M; Fukumoto S
J Cell Physiol; 2015 Apr; 230(4):922-9. PubMed ID: 25215620
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
Gu K; Zhang L; Jin T; Rutherford RB
Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
[TBL] [Abstract][Full Text] [Related]
15. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts.
Igarashi M; Kamiya N; Hasegawa M; Kasuya T; Takahashi T; Takagi M
J Mol Histol; 2004 Jan; 35(1):3-10. PubMed ID: 15323344
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells.
Chan GK; Miao D; Deckelbaum R; Bolivar I; Karaplis A; Goltzman D
Endocrinology; 2003 Dec; 144(12):5511-20. PubMed ID: 12960089
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors.
Açil Y; Ghoniem AA; Wiltfang J; Gierloff M
J Craniomaxillofac Surg; 2014 Dec; 42(8):2002-9. PubMed ID: 25458345
[TBL] [Abstract][Full Text] [Related]
18. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.
Celil AB; Campbell PG
J Biol Chem; 2005 Sep; 280(36):31353-9. PubMed ID: 16000303
[TBL] [Abstract][Full Text] [Related]
19. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway.
Li TF; Dong Y; Ionescu AM; Rosier RN; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
Exp Cell Res; 2004 Sep; 299(1):128-36. PubMed ID: 15302580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
